CCL Products FY26 Results; Q4 Conference Call Recording Available

5 min read     Updated on 09 May 2026, 05:00 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

CCL Products (India) Limited reported its audited standalone and consolidated financial results for Q4 and FY26, showing consolidated revenue growth to Rs. 4,45,737.34 lakhs and a net profit of Rs. 38,810.60 lakhs. The Board recommended a final dividend of Rs. 3.00 per share. Additionally, the company uploaded the audio recording of the May 8, 2026, conference call to its website in compliance with SEBI regulations.

powered bylight_fuzz_icon
39721481

*this image is generated using AI for illustrative purposes only.

CCL Products (India) Limited announced its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, following a Board of Directors meeting held on May 07, 2026. The meeting commenced at 03:20 P.M. and concluded at 05:00 P.M. The statutory auditors, M/s. Ramanatham & Rao, Chartered Accountants, issued audit reports with unmodified opinions on both the standalone and consolidated financial results. The results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013, and comply with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has uploaded the audio recording of the conference call held on May 8, 2026. The recording discusses the Q4 and full-year FY26 results and is accessible on the official website at www.cclproducts.com . The direct link to the audio file is https://www.cclproducts.com/wp-content/uploads/2026/05/Audio-recording-of-the-Q4-Results-Conference-Call-2025-26.mp3 .

Consolidated Financial Performance

The consolidated results encompass CCL Products (India) Limited along with its five subsidiaries — CCL Food and Beverages Private Limited, Continental Coffee Private Limited, Ngon Coffee Company Limited (Vietnam), Continental Coffee SA (Switzerland), and Jayanti Pte Limited (Singapore) — and its associate company, Mukkonda Renewables Private Limited. The following table summarises the key consolidated financial metrics:

Metric: Q4 FY26 Q4 FY25 FY26 FY25
Revenue from Operations (Rs. Lakhs): 1,22,444.38 83,584.76 4,45,737.34 3,10,574.99
Total Income (Rs. Lakhs): 1,22,638.98 83,965.37 4,46,580.46 3,11,420.35
Total Expenses (Rs. Lakhs): 1,10,324.85 73,377.08 4,00,510.64 2,76,195.03
EBITDA (Rs.): 1.9B 1.6B
EBITDA Margin (%): 15.67% 19.53%
Profit Before Tax (Rs. Lakhs): 12,314.13 10,588.29 46,069.82 35,225.33
Net Profit After Tax (Rs. Lakhs): 11,453.23 10,186.84 38,810.60 31,033.65
Total Comprehensive Income (Rs. Lakhs): 19,688.31 10,639.28 47,568.67 31,091.94
Basic EPS (Rs.): 8.60 7.65 20.15 13.33
Diluted EPS (Rs.): 8.59 7.64 29.10 23.26

On a year-on-year basis, Q4 FY26 consolidated net profit grew to Rs. 11,453.23 lakhs from Rs. 10,186.84 lakhs, while consolidated revenue expanded to Rs. 1,22,444.38 lakhs from Rs. 83,584.76 lakhs. Q4 EBITDA came in at Rs. 1.9B versus Rs. 1.6B in the same period last year, though the EBITDA margin contracted to 15.67% from 19.53% year-on-year. Consolidated cost of materials consumed for FY26 stood at Rs. 2,93,668.36 lakhs, compared to Rs. 1,91,454.32 lakhs in FY25. Employee benefits expense for the year was Rs. 19,281.87 lakhs, while depreciation was Rs. 15,192.65 lakhs and finance costs amounted to Rs. 12,874.99 lakhs.

Standalone Financial Performance

On a standalone basis, CCL Products reported a significant improvement across key financial parameters for FY26. The standalone operations relate to one reportable segment, and hence segmental reporting as per Ind AS 108 is not applicable.

Metric: Q4 FY26 Q4 FY25 FY26 FY25
Revenue from Operations (Rs. Lakhs): 55,776.60 44,789.98 2,21,605.13 1,71,799.71
Total Income (Rs. Lakhs): 65,068.95 45,580.24 2,38,991.59 1,73,190.90
Total Expenses (Rs. Lakhs): 53,769.33 42,605.39 2,04,079.52 1,60,145.58
Profit Before Tax (Rs. Lakhs): 11,299.62 2,974.85 34,912.07 13,045.32
Net Profit (Rs. Lakhs): 10,731.35 3,015.49 28,718.88 9,229.97
Total Comprehensive Income (Rs. Lakhs): 10,707.67 2,966.66 28,695.20 9,181.14
Basic EPS (Rs.): 8.06 2.26 21.56 6.93
Diluted EPS (Rs.): 8.05 2.26 21.54 6.92

Notably, standalone other income for FY26 was Rs. 17,386.46 lakhs, which includes Rs. 16,284.02 lakhs received from the company's wholly owned overseas subsidiary, M/s. Ngon Coffee Company Limited, Vietnam — comprising Rs. 7,042.12 lakhs for the quarter ended September 30, 2025, and Rs. 9,241.90 lakhs for the quarter ended March 31, 2026. Standalone employee benefit expenses for FY26 include Rs. 303.16 lakhs towards the CCL Employee Stock Option Scheme - 2022, accounted for as per Ind AS 102 - Share Based Payments.

Balance Sheet Highlights

The standalone total assets as at March 31, 2026 stood at Rs. 2,56,831.37 lakhs, compared to Rs. 2,36,508.87 lakhs as at March 31, 2025. Total standalone equity increased to Rs. 1,37,707.50 lakhs from Rs. 1,18,848.27 lakhs. On a consolidated basis, total assets as at March 31, 2026 were Rs. 4,32,629.09 lakhs against Rs. 4,24,097.70 lakhs in the prior year, with total consolidated equity rising to Rs. 2,34,455.48 lakhs from Rs. 1,96,722.77 lakhs.

Balance Sheet Metric: Standalone FY26 Standalone FY25 Consolidated FY26 Consolidated FY25
Total Assets (Rs. Lakhs): 2,56,831.37 2,36,508.87 4,32,629.09 4,24,097.70
Total Equity (Rs. Lakhs): 1,37,707.50 1,18,848.27 2,34,455.48 1,96,722.77
Other Equity (Rs. Lakhs): 1,35,036.94 1,16,177.71 2,31,784.92 1,94,052.21
Non-Current Borrowings (Rs. Lakhs): 1,666.67 3,473.96 37,673.14 55,630.48
Current Borrowings (Rs. Lakhs): 57,641.13 82,453.80 91,401.62 1,25,630.36

Cash Flow Summary

The standalone net cash from operating activities for the year ended March 31, 2026 was Rs. 32,436.18 lakhs, compared to Rs. 14,769.50 lakhs in the prior year. Standalone cash and cash equivalents at the end of the year stood at Rs. 1,050.08 lakhs. On a consolidated basis, net cash from operating activities was Rs. 85,828.54 lakhs for FY26 versus Rs. 28,969.07 lakhs in FY25, with consolidated cash and cash equivalents closing at Rs. 21,651.56 lakhs compared to Rs. 9,694.26 lakhs at the start of the year.

Dividend and Other Key Disclosures

The Board of Directors has recommended a final dividend of Rs. 3.00 per equity share (150%) of nominal value Rs. 2/- each for the financial year ended March 31, 2026, subject to approval by members at the ensuing Annual General Meeting. Additionally, during FY26, the company declared an interim dividend of Rs. 2.75 per equity share (137.50%) of nominal value of Rs. 2.00 each. The company also recognised an incremental impact on retiral benefits of Rs. 205.03 lakhs for the Group and Rs. 187.24 lakhs for the standalone entity for the year ended March 31, 2026, following the Government of India's notification on November 21, 2025, of four Labour Codes consolidating 29 existing labour laws. The paid-up equity share capital as at March 31, 2026 stood at Rs. 2,670.56 lakhs (face value Rs. 2/- per equity share).

Historical Stock Returns for CCL Products

1 Day5 Days1 Month6 Months1 Year5 Years
-7.01%-1.06%-2.01%+9.55%+45.37%+255.75%

How will CCL Products address the EBITDA margin compression from 19.53% to 15.67% in Q4 FY26, and what strategies are planned to restore margins amid rising raw material costs?

Given the significant revenue contribution from the Vietnam subsidiary (Ngon Coffee Company), how exposed is CCL Products to geopolitical and currency risks in Southeast Asia, and what hedging strategies are in place?

With non-current borrowings declining sharply from Rs. 55,630 lakhs to Rs. 37,673 lakhs consolidated, how does CCL Products plan to deploy its improved cash flows — towards capacity expansion, acquisitions, or further debt reduction?

CCL Products Grants 1,61,850 Stock Options Under ESOP Scheme-2022, Revises Senior Management List

2 min read     Updated on 08 May 2026, 03:13 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

CCL Products (India) Limited's Nomination and Remuneration Committee, at its meeting on 07 May 2026, approved the grant of 1,61,850 stock options and vesting of 1,48,473 options under the CCL Employee Stock Option Scheme-2022, with 6,475 options lapsed due to employee resignations. The committee also approved the reclassification of Senior Management Personnel, comprising six key executives including the CEO, CFO, and Company Secretary, in line with the current organisational structure.

powered bylight_fuzz_icon
39734491

*this image is generated using AI for illustrative purposes only.

CCL Products (India) Limited's Nomination and Remuneration Committee, at its meeting held on 07th May 2026, approved the grant of 1,61,850 stock options and the vesting of 1,48,473 options under the CCL Employee Stock Option Scheme-2022. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In the same meeting, the committee also approved structural and organisational changes to the company's Senior Management Personnel.

ESOP Grant and Vesting Details

The CCL Employee Stock Option Scheme-2022 is compliant with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The newly granted options carry an exercise price of Rs.2/- per share at face value, and eligible employees may exercise their options within 2 years from the respective date of vesting. Vesting is contingent upon employees achieving earmarked targets for the respective years, as determined by the Nomination and Remuneration Committee.

The following table summarises the key details of the ESOP activity disclosed under Annexure-1:

Parameter: Details
Options Granted: 1,61,850 options under CCL Employee Stock Option Scheme-2022
Options Vested: 1,48,473 options under CCL Employee Stock Option Scheme-2022
Options Lapsed/Forfeited: 6,475 options (due to resignation of eligible employees)
Exercise Price: Rs.2/- per share (at Face Value)
Shares Covered: Equity Shares of Rs.2/- each against 1,61,850 options
Exercise Window: Within 2 years from the date of vesting
Scheme Compliance: SEBI (SBEB) Regulations, 2021
Vesting Criteria: Upon achieving earmarked targets for respective years

It was also noted that 6,475 options have lapsed or been forfeited following the resignation of eligible employees. Options exercised, money realised by exercise, and total shares arising from exercise were reported as not applicable at this stage.

Revised Senior Management Personnel

In addition to the ESOP-related decisions, the Nomination and Remuneration Committee took note of structural and organisational changes within the company. The committee approved the redefinition and reclassification of Senior Management Personnel in accordance with Regulation 16(1)(d) read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, aligned with the current organisational structure and reporting hierarchy.

The revised list of Senior Management Personnel is as follows:

S. No.: Employee Name Designation
1 Praveen Jaipuriar Chief Executive Officer
2 Chaitanya Agasthyaraju Chief Financial Officer
3 Sridevi Dasari Company Secretary & Compliance Officer
4 Srinivas Atla Chief Human Resources Officer
5 Suyash Mehrotra Head – Business Development
6 B. Vaishak Head - Operations

The intimation was signed by Sridevi Dasari, Company Secretary & Compliance Officer, on behalf of CCL Products (India) Limited, and submitted to both the National Stock Exchange of India Limited and BSE Limited as required under the applicable SEBI regulations.

Historical Stock Returns for CCL Products

1 Day5 Days1 Month6 Months1 Year5 Years
-7.01%-1.06%-2.01%+9.55%+45.37%+255.75%

How might the performance-linked vesting criteria for the newly granted ESOPs influence employee retention and productivity at CCL Products, particularly given the 6,475 options already forfeited due to resignations?

What strategic shifts in CCL Products' business direction could the reorganization of Senior Management Personnel signal, especially with the inclusion of a dedicated Head of Business Development?

Given the exercise price of Rs.2/- per share against current market valuations, how significantly could the eventual exercise of 1,48,473 vested options impact CCL Products' equity dilution and earnings per share?

More News on CCL Products

1 Year Returns:+45.37%